Stay updated on Dapagliflozin in Acute Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin in Acute Heart Failure Clinical Trial page.

Latest updates to the Dapagliflozin in Acute Heart Failure Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page revision was updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.1%

- Check30 days agoChange DetectedNo substantive changes detected; core study details appear unchanged.SummaryDifference0.1%

- Check51 days agoChange DetectedAdded a site revision tag (Revision: v3.4.2) and removed older funding-status notices (Revision: v3.4.1). These changes affect only the site metadata and do not modify the study details or eligibility information.SummaryDifference0.5%

- Check58 days agoChange DetectedA site-wide notice about government funding and NIH operations was added. The site revision number was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check65 days agoChange DetectedAdded a Show glossary option and new metadata labels 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', plus a page revision note 'Revision: v3.4.0'. Older labels 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' were removed and the revision updated from v3.3.4 to v3.4.0.SummaryDifference0.2%

Stay in the know with updates to Dapagliflozin in Acute Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin in Acute Heart Failure Clinical Trial page.